Literature DB >> 9094085

Detection of glutamate/glutamine resonances by 1H magnetic resonance spectroscopy at 0.5 tesla.

R W Prost1, L Mark, M Mewissen, S J Li.   

Abstract

Midfield proton magnetic resonance spectroscopy (MRS) provides a noninvasive method to monitor glutamate and glutamine (Glx) levels in vivo. Experiments to detect the gamma and beta resonances of Glx have been performed by using commercial 0.5 T and 1.5 T MR scanners on seven patients with elevated blood ammonia and eight normal volunteers. Compared with the spectral sensitivity obtained on an otherwise identical system operating at 1.5 T, the singlet resonance of N-acetyl aspartate (NAA) was decreased by a factor of 1.48, which is significantly less than expected using the ratio of Boltzman populations at the two field strengths. However, the resonances of Glx at 0.5 T increased in signal-to-noise ratio (SNR) by a factor of 2. The increased SNR of Glx is principally due to improved B0 main-field homogeneity and collapse of the strongly J-coupled Glx resonances. Our preliminary results suggest that midfield proton MRS will provide significant clinical utility in the detection of Glx levels in human brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094085     DOI: 10.1002/mrm.1910370422

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  5 in total

Review 1.  Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.

Authors:  L P Mark; R W Prost; J L Ulmer; M M Smith; D L Daniels; J M Strottmann; W D Brown; L Hacein-Bey
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 2.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

3.  In vivo detection of postictal perturbations of cerebral metabolism by use of proton MR spectroscopy: preliminary results in a canine model of prolonged generalized seizures.

Authors:  R Neppl; C M Nguyen; W Bowen; T Al-Saadi; J Pallagi; G Morris; W Mueller; R Johnson; R Prost; S D Rand
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

4.  Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model.

Authors:  J Butzen; R Prost; V Chetty; K Donahue; R Neppl; W Bowen; S J Li; V Haughton; L Mark; T Kim; W Mueller; G Meyer; H Krouwer; S Rand
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 5.  MR-Guided Radiotherapy for Brain and Spine Tumors.

Authors:  Danilo Maziero; Michael W Straza; John C Ford; Joseph A Bovi; Tejan Diwanji; Radka Stoyanova; Eric S Paulson; Eric A Mellon
Journal:  Front Oncol       Date:  2021-03-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.